LAM Group
PFE icon

LAM Group’s Pfizer PFE Stock Holding History

LAM Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.8K Hold
483
– – 0.01% 102
2026
Q2 		$11.6K Hold
483
– – 0.01% 106
2026
Q1 		$13.6K Buy
+483
New +$12.9K 0.01% 101
2025
Q1 		– Sell
-483
Closed -$12.8K – 111
2024
Q4 		$12.8K Hold
483
– – 0.01% 98
2024
Q3 		$14K Hold
483
– – 0.01% 96
2024
Q2 		$13.5K Hold
483
– – 0.01% 93
2024
Q1 		$13.4K Hold
483
– – 0.01% 93
2023
Q4 		$13.9K Sell
483
-3
-0.6% -$91 0.01% 86
2023
Q3 		$16.1K Hold
486
– – 0.02% 77
2023
Q2 		$17.8K Hold
486
– – 0.02% 74
2023
Q1 		$19.8K Hold
486
– – 0.02% 71
2022
Q4 		$24.9K Buy
+486
New +$23.3K 0.03% 72

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

LAM Group's PFE Position: Q3 2026 in Review

LAM Group held its Pfizer (PFE) position steady in Q3 2026 at 483 shares worth $13.8K. The position accounts for 0.01% of the portfolio, ranked #102.

LAM Group first reported a position in PFE in Q4 2022 and has held it in 12 quarters since. The position peaked at $24.9K in Q4 2022. 1,266 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • LAM Group held 483 shares of Pfizer worth $13.8K as of Q3 2026.
  • LAM Group left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.01% of LAM Group's portfolio in Q3 2026, its #102 holding.
  • LAM Group first reported a position in Pfizer in Q4 2022 and has held it in 12 quarters since.
  • LAM Group's Pfizer position peaked at $24.9K in Q4 2022.
  • 1,266 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on LAM Group's 13F filing for Q3 2026, filed 26 Oct 2026.